Novel heterocyclic compound
OwnerToru Kodo, Takayuki Fukaya +3inventors
InventorsToru Kodo, Takayuki Fukaya, Koji Koyama, Shuji Masumoto, Nao Fujibayashi
Life of this patent
Estimating the term…
Loading patent…
OwnerToru Kodo, Takayuki Fukaya +3inventors
InventorsToru Kodo, Takayuki Fukaya, Koji Koyama, Shuji Masumoto, Nao Fujibayashi
Estimating the term…
A drug having a high affinity for benzodiazepine ω3 receptors and showing curative and preventive effects for anxiety and depression, which comprises as the active ingredient, for example, a compound of the formula (1): wherein R1 and R2 are independently a hydrogen atom, an optionally substituted alkyl group, an optionally substituted aryl group, etc., R3 and R4 are independently a hydrogen atom, an optionally substituted alkyl group, etc., R5, R6, R7 and R8 are independently a hydrogen atom, an optionally substituted alkyl group, an optionally substituted aryl group, etc., X is an oxygen atom, a sulfur atom, NR10, etc. (in which R10 is a hydrogen atom, an optionally substituted alkyl group, etc.)
An antianxiety or antidepressant agent comprising a compound of the formula (1):
A compound of the formula (1′):
Dependencies are inferred from the claim text.